154eP Real-world effectiveness and resource utilization of first-line pembrolizumab in NSCLC: A retrospective observational study (MOSAICO study)
Antonio Ungaro, M. Calcagno, Tiziana Guarino, L. Brandi et autres
it, cz (code pays fourni par la source)